Pharmacokinetics and bioavailability study of l-ornithine–l-aspartate in healthy volunteers—A comparative study of two oral formulations

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study

G. Kircheis, R Nilius, Claes Held et al. · Hepatology · 1997 · 318 citations · Full text

Medicine, Internal Medicine, Pharmacology +15

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study

S Stauch, G. Kircheis, Guideo Adler et al. · Journal of Hepatology · 1998 · 169 citations

Medicine, Pharmacology, Pharmacotherapy +10

Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design

U. Staedt, H. Leweling, R. Gladisch et al. · Journal of Hepatology · 1993 · 102 citations

Medicine, Internal Medicine, Pharmacology +12

Dispelling myths in the treatment of hepatic encephalopathy

Debbie L. Shawcross, Rajiv Jalan · The Lancet · 2005 · 97 citations

Medicine, Internal Medicine, Pharmacology +11

Effect of l-ornithine-l-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

Colin Rees · Gut · 2000 · 67 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15